Monte Rosa Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Monte Rosa Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Monte Rosa Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Monte Rosa Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $345k | 92k | 3.74 |
| 2024-03-31 | $111k | 16k | 7.05 |
| 2023-12-31 | $210k | 37k | 5.65 |
| 2023-09-30 | $260k | 54k | 4.79 |
| 2023-06-30 | $311k | 45k | 6.85 |
| 2023-03-31 | $251k | 32k | 7.79 |
| 2022-12-31 | $335k | 44k | 7.61 |
| 2022-06-30 | $388k | 40k | 9.67 |
| 2022-03-31 | $698k | 50k | 14.01 |
| 2021-12-31 | $710k | 35k | 20.43 |
| 2021-09-30 | $426k | 19k | 22.28 |